TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT01181921

The CIRCADIAN Study: Evaluation of Modulating Effect of Galantamine on Circadian Rhythm in Patients With Mild to Moderate Alzheimer's Disease

Cause of deathSlow enrollment Automatic label, confidence 0.9, unverified. How labels are made.
“The recruitment rate was very low (one screening failure and one early withdrawal patient)”

The sponsor’s own words in the registry.

Life of this trial

2010201120122013Registered2010-08-12Started2011-05Stopped2011-06Results posted2012-08-14

Vital statistics

Status
Terminated
Phase
Phase 4
Sponsor
Janssen-Cilag, S.A.
Sponsor type
Industry
Conditions
Alzheimer Disease
Interventions
Galantamine
Participants
1
Sites
1
Countries
Spain

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.